{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:59:42Z","timestamp":1786982382581,"version":"build-2736575974"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s12328-025-02246-4","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T09:49:27Z","timestamp":1763113767000},"page":"157-163","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Durable response to chemotherapy enabling conversion surgery in stage IVB gallbladder cancer: a case successfully treated with durvalumab combined with gemcitabine plus cisplatin"],"prefix":"10.1007","volume":"19","author":[{"given":"Masahiro","family":"Yamaguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7480-7283","authenticated-orcid":false,"given":"Shunsuke","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rihwa","family":"Om","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Kita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayato","family":"Murata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Genda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"key":"2246_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41572-022-00398-y","volume":"8","author":"JC Roa","year":"2022","unstructured":"Roa JC, Garc\u00eda P, Kapoor VK, et al. Gallbladder cancer. Nat Rev Dis Primers. 2022;8:69.","journal-title":"Nat Rev Dis Primers"},{"key":"2246_CR2","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","volume":"362","author":"J Valle","year":"2010","unstructured":"Valle J, Wasan H, Palmer DH, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362:1273\u201381.","journal-title":"N Engl J Med"},{"key":"2246_CR3","doi-asserted-by":"publisher","first-page":"EVIDoa2200015","DOI":"10.1056\/EVIDoa2200015","volume":"1","author":"DY Oh","year":"2022","unstructured":"Oh DY, Ruth He A, Qin S, et al. Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer. NEJM Evid. 2022;1:EVIDoa2200015.","journal-title":"NEJM Evid"},{"key":"2246_CR4","doi-asserted-by":"crossref","unstructured":"Bismuth H, Adam R, L\u00e9vi F, et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg. 224: 509\u2013520; discussion 520\u20132, 1996.","DOI":"10.1097\/00000658-199610000-00009"},{"key":"2246_CR5","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1097\/01.sla.0000141194.27992.32","volume":"240","author":"A Habr-Gama","year":"2004","unstructured":"Habr-Gama A, Perez RO, Nadalin W, et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg. 2004;240:711\u20138.","journal-title":"Ann Surg"},{"key":"2246_CR6","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s10120-015-0575-z","volume":"19","author":"K Yoshida","year":"2016","unstructured":"Yoshida K, Yamaguchi K, Okumura N, et al. Is conversion therapy possible in stage IV gastric cancer: the proposal of new biological categories of classification. Gastric Cancer. 2016;19:329\u201338.","journal-title":"Gastric Cancer"},{"key":"2246_CR7","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1007\/s00534-013-0616-0","volume":"20","author":"S Satoi","year":"2013","unstructured":"Satoi S, Yamaue H, Kato K, et al. Role of adjuvant surgery for patients with initially unresectable pancreatic cancer with a long\u2010term favorable response to non\u2010surgical anti\u2010cancer treatments: results of a project study for pancreatic surgery by the Japanese Society of Hepato\u2010Biliary\u2010Pancreatic Surgery. J Hepatobiliary Pancreat Sci. 2013;20:590\u2013600.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"2246_CR8","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00595-020-02031-5","volume":"50","author":"T Noji","year":"2020","unstructured":"Noji T, Nagayama M, Imai K, et al. Conversion surgery for initially unresectable biliary malignancies: a multicenter retrospective cohort study. Surg Today. 2020;50:1409\u201317.","journal-title":"Surg Today"},{"key":"2246_CR9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00423-025-03630-x","volume":"410","author":"Y Zhou","year":"2025","unstructured":"Zhou Y, Wang Q, Lin M, et al. Survival benefit of conversion surgery for initially unresectable biliary tract cancer: a systematic review and meta-analysis. Langenbecks Arch Surg. 2025;410:63.","journal-title":"Langenbecks Arch Surg"},{"key":"2246_CR10","doi-asserted-by":"publisher","first-page":"107694","DOI":"10.1016\/j.ijscr.2022.107694","volume":"100","author":"F Al Jaber","year":"2022","unstructured":"Al Jaber F, Almaher E, Al-Ibrahim R, et al. Curative surgical resection for initially unresectable metastatic gallbladder cancer following neoadjuvant chemotherapy: case report and review of literature. Int J Surg Case Rep. 2022;100:107694.","journal-title":"Int J Surg Case Rep"},{"key":"2246_CR11","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s40792-022-01406-9","volume":"8","author":"Y Wakasa","year":"2022","unstructured":"Wakasa Y, Toyoki Y, Kusumi T, et al. Conversion surgery following gemcitabine plus cisplatin therapy for initially unresectable gallbladder cancer with peritoneal carcinomatosis: a case report. Surg Case Rep. 2022;8:50.","journal-title":"Surg Case Rep"},{"key":"2246_CR12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40792-022-01375-z","volume":"8","author":"Y Miura","year":"2022","unstructured":"Miura Y, Ashida R, Sugiura T, et al. Pathological complete response achieved by gemcitabine plus cisplatin therapy for initially unresectable advanced gallbladder cancer: a case report. Surg Case Rep. 2022;8:20.","journal-title":"Surg Case Rep"},{"key":"2246_CR13","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s12328-024-02053-3","volume":"18","author":"T Araki","year":"2025","unstructured":"Araki T, Muranushi R, Takagi K, et al. A case of successful conversion surgery for unresectable gallbladder cancer treated with durvalumab in combination with gemcitabine plus cisplatin. Clin J Gastroenterol. 2025;18:161\u20138.","journal-title":"Clin J Gastroenterol"},{"key":"2246_CR14","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0140-6736(22)02038-4","volume":"401","author":"K Nakachi","year":"2023","unstructured":"Nakachi K, Ikeda M, Konishi M, et al. Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, Ascot): a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet. 2023;401:195\u2013203.","journal-title":"Lancet"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-025-02246-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-025-02246-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-025-02246-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T08:45:21Z","timestamp":1771663521000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-025-02246-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["2246"],"URL":"https:\/\/doi.org\/10.1007\/s12328-025-02246-4","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"value":"1865-7257","type":"print"},{"value":"1865-7265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"assertion":[{"value":"13 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare no conflict of interest for this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted in accordance with the ethical standards of the Declaration of Helsinki. Ethical approval was obtained from the institutional review board of Juntendo University Shizuoka Hospital (Approval No. SH25-24).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Consent was obtained from the patient for publication of this case report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}